Author

Junichi Omura

Institution: Janssen Pharmaceutical K.K. (Japan)

Observed institution: Janssen Pharmaceutical K.K. (Japan)

ORCID: 0000-0002-6015-5739

Observed ORCID: 0000-0002-6015-5739

OpenAlex ID: A5017091265

Real‐world clinical practice of pulmonary arterial hypertension in Japan: Insights from a large administrative database

2023 · Junichi Omura, Kazuki Kitahara, et al. · Pulmonary Circulation · 8

Treatment pattern and clinical outcomes in portopulmonary hypertension: A database study in Japan

2022 · Masanori Atsukawa, Masashi Takano, et al. · JGH Open · 7

Comparative Treatment Persistence and Adherence to Endothelin Receptor Antagonists Among Patients with Pulmonary Arterial Hypertension in Japan: A Real-World Administrative Claims Database Study

2023 · Junichi Omura, Yogeshwar Makanji, et al. · Pulmonary Therapy · 5

A PrOsPective Cohort Study on Interstitial Lung Disease-Associated Pulmonary Hypertension with a ParticulaR Focus on the Subset with Pulmonary Arterial Hypertension Features (POPLAR Study)

2024 · Ichizo Tsujino, Kazuki Kitahara, et al. · Pulmonary Therapy · 2

Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database

2023 · Kazuki Kitahara, Junichi Omura, et al. · Pulmonary Therapy · 2

Correction: Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database

2023 · Kazuki Kitahara, Junichi Omura, et al. · Pulmonary Therapy

Works count: 6

Citation count: 24

H-index: 3

I10-index: